A Proof of Concept for CRISPR-Cas9 Use in Arabidopsis Thaliana in Undergraduate Research at the University of Lynchburg
Location
Access Type
Campus Access Only
Entry Number
68
Start Date
4-7-2021 1:45 PM
End Date
4-7-2021 2:00 PM
Department
Biomedical Science
Abstract
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) and the Cas9 nuclease enzyme work as an editing software for DNA. Bacteria use this technology to cleave a piece of any foreign DNA entering a cell and render it useless. However, the CRISPR-Cas9 system can be modified to downregulate any targeted gene in an organism. Scientists have already been successful in transforming CRISPR-Cas9 into eukaryotic cells. The system can be programmed with guide RNA to find a specific section of a genome to cleave. This allows for specific downregulation of any target genes or genes in a cell. The model plant Arabidopsis thaliana is an ideal genetic candidate for the use of CRISPR-Cas9 because the full genome has been sequenced, it has a small genome, and it has a short life cycle. Using a floral dipping method, CRISPR-Cas9 will be introduced to Arabidopsis thaliana to downregulate candidate genes that should affect the plant’s phenotype. The main goal of this thesis is to create a system for CRISPR- Cas9 research at the University of Lynchburg that is accurate, precise, and easy to use. This will be done using two genes, TOO MANY MOUTHS (TMM) and VARIEGATED 1 (VAR1), which are two genes with known function and clear phenotypes. Plants in which TMM is mutated display increased stomatal density, and VAR1 mutants contain downregulated genes involved in photosystem II, leading to stunted growth. Once CRISPR-Cas9 can be used successfully at the University of Lynchburg, future researchers can use it to target genes of interest to determine their functions.
Faculty Mentor(s)
Dr. Erin FriedmanDr. Beth SavageDr. Jamie BrooksDr. Domenica Favero
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
A Proof of Concept for CRISPR-Cas9 Use in Arabidopsis Thaliana in Undergraduate Research at the University of Lynchburg
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) and the Cas9 nuclease enzyme work as an editing software for DNA. Bacteria use this technology to cleave a piece of any foreign DNA entering a cell and render it useless. However, the CRISPR-Cas9 system can be modified to downregulate any targeted gene in an organism. Scientists have already been successful in transforming CRISPR-Cas9 into eukaryotic cells. The system can be programmed with guide RNA to find a specific section of a genome to cleave. This allows for specific downregulation of any target genes or genes in a cell. The model plant Arabidopsis thaliana is an ideal genetic candidate for the use of CRISPR-Cas9 because the full genome has been sequenced, it has a small genome, and it has a short life cycle. Using a floral dipping method, CRISPR-Cas9 will be introduced to Arabidopsis thaliana to downregulate candidate genes that should affect the plant’s phenotype. The main goal of this thesis is to create a system for CRISPR- Cas9 research at the University of Lynchburg that is accurate, precise, and easy to use. This will be done using two genes, TOO MANY MOUTHS (TMM) and VARIEGATED 1 (VAR1), which are two genes with known function and clear phenotypes. Plants in which TMM is mutated display increased stomatal density, and VAR1 mutants contain downregulated genes involved in photosystem II, leading to stunted growth. Once CRISPR-Cas9 can be used successfully at the University of Lynchburg, future researchers can use it to target genes of interest to determine their functions.